A new study has found that the use of a specific at-home urine test could detect bladder cancer with accuracy. Here are its ...

Urinary bladder cancer can begin with symptoms that look like a UTI, prostate problem or simply ageing. Here are the early ...

Despite falling short of analyst expectations, Tyra Biosciences is taking its cancer drug to registrational development for ...

Remission rates observed in a Phase 2 trial fell short of Wall Street's expectations, though some analysts believe the ...

In this study, researchers aimed to evaluate bladder cancer trial availability across US counties and its associations with bladder cancer incidence and mortality.

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...

A study co-author told Newsweek the test is already helping some National Health Service sites clear cystoscopy backlogs.

Tyra Biosciences has reported initial phase 2 data on dabogratinib in bladd | Tyra Biosciences has reported initial phase 2 ...

Shares of Tyra Biosciences fell after the company said some patients in a mid-stage trial of its treatment for certain types of bladder cancer reported side effects such as fatigue, diarrhea and dry ...

Tyra is set to host a conference call on September 9 to discuss initial results from its Phase 2 study evaluating ...